Table 1 Patient characteristics of sarcoma patients enrolled on phase I trials.
Characteristic | Total (N = 100) | Soft Tissue Sarcoma (N = 79) | Bone Sarcoma (N = 21) |
|---|---|---|---|
Sex | |||
Male | 46 | 35 | 11 |
Female | 54 | 44 | 10 |
Age (years) | |||
Median (range) | 48 (14–80) | 49 (16–80) | 29 (14–70) |
Ethnicity | |||
White | 76 | 58 | 18 |
Black | 13 | 12 | 1 |
Hispanic | 8 | 6 | 2 |
Asian | 3 | 3 | 0 |
No. of metastatic sites | |||
<3 | 62 | 48 | 14 |
≥3 | 38 | 31 | 7 |
LDH | |||
≤ULN | 79 | 61 | 18 |
>ULN | 21 | 18 | 3 |
Albumin | |||
≥3.5 g/dL | 92 | 71 | 21 |
<3.5 g/dL | 8 | 8 | 0 |
No. of prior therapies | |||
<3 | 51 | 42 | 9 |
≥3 | 49 | 37 | 12 |
